goBalto, Inc. expands Tracker 2.0's analytics and submissions features

SAN FRANCISCO, Oct. 29, 2013 /PRNewswire/ -- goBalto, Inc. announced today that the latest release of its signature product, Tracker 2.0, is now available.

With its 9th release, Tracker adds critical path reporting and a submissions manager. Now, clinical study managers can view the percentage of sites activated and the milestones blocking study startup completion, without having to wait for status reports that normally take up to a week.

The new critical path reports show all the documents and submissions along the critical path to key company milestones, and the overall status of all milestones for a study. There's a version that's suitable for country managers and another for printing and sending to sponsors.

The submissions manager allows specialists to plan and track documents to be included in an ethics or regulatory committee submission. A submission status report shows which study country and site documents are complete for a submission, and which ones are still in progress.

Jae Chung, founding CEO of goBalto, stated, "The life sciences industry is continually seeking ways to be more efficient in how they get their clinical studies started. Our new release focuses on innovation, going to the heart of how we can best help our partners quickly identify and resolve bottlenecks. In this critical phase of the process, our customers can't afford to wait multiple days for status or wonder how ready they are to complete a submission."

About goBalto

goBalto develops next-generation solutions that simplify how clinical trials are started in the pharmaceutical, biotechnology, and medical device industries. Our flagship product, Tracker, is a purpose-built software-as-a-service clinical research platform. It enables clinical trial sponsors and research organizations to track milestones on the critical path, and provides document workflow management capabilities in a transparent, regulatory-compliant, and user-friendly way. Founded in 2008 in Silicon Valley by biotechnology industry veteran Jae Chung, goBalto is backed by leading health technology investors. For more information, visit www.gobalto.com.

CONTACT: Maria Breaux, 415 994 5040, [email protected]

Video with caption: "goBalto CEO and founder Jae Chung introduces the latest release of Tracker 2.0. With this release, Tracker adds critical path reporting and a submissions manager. Now, clinical study managers can view the percentage of sites activated and milestones blocking study startup completion, without having to wait for status reports that normally take up to a week. The submissions manager allows study startup specialists to specify country and site documents to include and track in a submission package." Video available at: http://youtu.be/JqvCJ2dehD0

SOURCE goBalto